Skip to content
OpenCapital
Get started

PDS Biotechnology Corporation PDSB Q4 2025 Annual earnings

Reported March 30, 2026 · Before market open

Diluted EPS-$0.14Beat by $0.06
EPS estimate-$0.20

Next report

Aug 12, 2026 (in a month)
EPS estimate-$0.13

Versus estimates

Diluted EPS

Q1 2026-$0.13Beat by $0.02
Q4 2025-$0.14Beat by $0.06
Q3 2025-$0.19Beat by $0.02Q2 2025-$0.21Beat by $0.03Q1 2025-$0.21Beat by $0.04Q4 2024-$0.21Beat by $0.08

Ask the moment PDS Biotechnology Corporation reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did PDS Biotechnology Corporation report Q4 2025 earnings?
PDS Biotechnology Corporation (PDSB) reported Q4 2025 earnings on March 30, 2026 before market open.
What were PDS Biotechnology Corporation's Q4 2025 revenue and EPS?
PDS Biotechnology Corporation reported diluted EPS of $-0.14 for Q4 2025.
Did PDS Biotechnology Corporation beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.20 by $0.06.
How did PDS Biotechnology Corporation's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 33.3% from $-0.21.
Where can I find PDS Biotechnology Corporation's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001140361-26-011862) and the 10-K periodic report (0001140361-26-012030) directly on SEC EDGAR. The filing index links above go to sec.gov.